These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35255343)

  • 1. Novel metronidazole-derived three-component hybrids as promising broad-spectrum agents to combat oppressive bacterial resistance.
    Li FF; Zhang PL; Tangadanchu VKR; Li S; Zhou CH
    Bioorg Chem; 2022 May; 122():105718. PubMed ID: 35255343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfonamide-Derived Four-Component Molecular Hybrids as Novel DNA-Targeting Membrane Active Potentiators against Clinical Escherichia coli.
    Hu YY; Yadav Bheemanaboina RR; Battini N; Zhou CH
    Mol Pharm; 2019 Mar; 16(3):1036-1052. PubMed ID: 30638386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique iminotetrahydroberberine-corbelled metronidazoles as potential membrane active broad-spectrum antibacterial agents.
    Ansari MF; Tan YM; Sun H; Li S; Zhou CH
    Bioorg Med Chem Lett; 2022 Nov; 76():129012. PubMed ID: 36182008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel phenylhydrazone-based oxindole-thiolazoles as potent antibacterial agents toward Pseudomonas aeruginosa.
    Li FF; Zhao WH; Tangadanchu VKR; Meng JP; Zhou CH
    Eur J Med Chem; 2022 Sep; 239():114521. PubMed ID: 35716514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Unique Quinazolone Thiazoles as Novel Structural Scaffolds for Potential Gram-Negative Bacterial Conquerors.
    Wang J; Ansari MF; Zhou CH
    J Med Chem; 2021 Jun; 64(11):7630-7645. PubMed ID: 34009979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A New Discovery of Unique 13-(Benzimidazolylmethyl)berberines as Promising Broad-Spectrum Antibacterial Agents.
    Sun H; Li ZZ; Jeyakkumar P; Zang ZL; Fang B; Zhou CH
    J Agric Food Chem; 2022 Oct; 70(39):12320-12329. PubMed ID: 36135960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrimidine-conjugated fluoroquinolones as new potential broad-spectrum antibacterial agents.
    Tan YM; Li D; Li FF; Fawad Ansari M; Fang B; Zhou CH
    Bioorg Med Chem Lett; 2022 Oct; 73():128885. PubMed ID: 35835379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane-active amino acid-coupled polyetheramine derivatives with high selectivity and broad-spectrum antibacterial activity.
    Li H; Li Y; Wang Y; Liu L; Dong H; Satoh T
    Acta Biomater; 2022 Apr; 142():136-148. PubMed ID: 35158080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural Berberine-derived Azolyl Ethanols as New Structural Antibacterial Agents against Drug-Resistant
    Sun H; Huang SY; Jeyakkumar P; Cai GX; Fang B; Zhou CH
    J Med Chem; 2022 Jan; 65(1):436-459. PubMed ID: 34964345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzenesulfonyl thiazoloimines as unique multitargeting antibacterial agents towards Enterococcus faecalis.
    Zhou XM; Hu YY; Fang B; Zhou CH
    Eur J Med Chem; 2023 Feb; 248():115088. PubMed ID: 36623329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The in-vitro activity of metronidazole against strains of Escherichia coli with impaired DNA repair systems.
    Jackson D; Salem A; Coombs GH
    J Antimicrob Chemother; 1984 Mar; 13(3):227-36. PubMed ID: 6373714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of rdxA and involvement of additional genes encoding NAD(P)H flavin oxidoreductase (FrxA) and ferredoxin-like protein (FdxB) in metronidazole resistance of Helicobacter pylori.
    Kwon DH; El-Zaatari FA; Kato M; Osato MS; Reddy R; Yamaoka Y; Graham DY
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2133-42. PubMed ID: 10898687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of unique thiazolidinone-conjugated coumarins as novel broad spectrum antibacterial agents.
    Yang XC; Zhang PL; Kumar KV; Li S; Geng RX; Zhou CH
    Eur J Med Chem; 2022 Mar; 232():114192. PubMed ID: 35168149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Biological Evaluation of Piperazine Hybridized Coumarin Indolylcyanoenones with Antibacterial Potential.
    Zeng C; Avula SR; Meng J; Zhou C
    Molecules; 2023 Mar; 28(6):. PubMed ID: 36985486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, molecular docking and biological evaluation of metronidazole derivatives containing piperazine skeleton as potential antibacterial agents.
    Wang SF; Yin Y; Qiao F; Wu X; Sha S; Zhang L; Zhu HL
    Bioorg Med Chem; 2014 Apr; 22(8):2409-15. PubMed ID: 24680059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Bacterial Topoisomerase Inhibitors with Potent Broad-Spectrum Activity against Drug-Resistant Bacteria.
    Charrier C; Salisbury AM; Savage VJ; Duffy T; Moyo E; Chaffer-Malam N; Ooi N; Newman R; Cheung J; Metzger R; McGarry D; Pichowicz M; Sigerson R; Cooper IR; Nelson G; Butler HS; Craighead M; Ratcliffe AJ; Best SA; Stokes NR
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydropyrimidinone imidazoles as unique structural antibacterial agents for drug-resistant gram-negative pathogens.
    Yang X; Sun H; Maddili SK; Li S; Yang RG; Zhou CH
    Eur J Med Chem; 2022 Mar; 232():114188. PubMed ID: 35168152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel hybrids of metronidazole and quinolones: synthesis, bioactive evaluation, cytotoxicity, preliminary antimicrobial mechanism and effect of metal ions on their transportation by human serum albumin.
    Cui SF; Peng LP; Zhang HZ; Rasheed S; Vijaya Kumar K; Zhou CH
    Eur J Med Chem; 2014 Oct; 86():318-34. PubMed ID: 25173851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
    Kassab AE; Gedawy EM
    Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.